Kornberg Roger D. has filed 6 insider transactions across 2 companies since July 2023.
Most recent transaction: a grant/award of 24615 shares of Cocrystal Pharma, Inc. ($COCP) on January 09, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 9, 2026 | Cocrystal Pharma, Inc. | $COCP | Kornberg Roger D. | Director | A | Stock Options (Right to Buy) | 24615 | $0.00 | 24,615.0000 | 13,784,065 | 9999.99% | 0.18% |
| Dec. 31, 2025 | Xenetic Biosciences, Inc. | $XBIO | Kornberg Roger D. | Director | A | Stock Options | 2500 | $0.00 | 2,500.0000 | 2,291,056 | 9999.99% | 0.11% |
| Dec. 11, 2024 | Xenetic Biosciences, Inc. | $XBIO | Kornberg Roger D. | Director | A | Stock Options | 2500 | $0.00 | 2,500.0000 | 0 | 9999.99% | 0.00% |
| Oct. 9, 2024 | Cocrystal Pharma, Inc. | $COCP | Kornberg Roger D. | Director | A | Common Stock | 28109 | $0.00 | 67,878.0000 | 0 | 70.68% | 0.00% |
| Dec. 6, 2023 | Xenetic Biosciences, Inc. | $XBIO | Kornberg Roger D. | Director | A | Stock Options | 2500 | $0.00 | 2,500.0000 | 0 | 9999.99% | 0.00% |
| July 18, 2023 | Cocrystal Pharma, Inc. | $COCP | Kornberg Roger D. | Director | A | Stock Options (Right to Buy) | 24417 | $0.00 | 24,417.0000 | 0 | 9999.99% | 0.00% |